I want to know the answer to the following question:
What could help to spur pharmaceuticals to make new antibiotics?
All the background I'm provided with is that "According to Allan Coukell, senior director for health programs at The Pew Charitable Trusts, "By allowing drug developers to rely on smaller datasets, and clarifying FDA's authority to tolerate a higher level of uncertainty for these drugs when making a risk/benefit calculation, ADAPT would make the clinical trials more feasible."". Is that enough to answer the question?
Answer: no